Ligand Pharmaceuticals Inc.

530 articles about Ligand Pharmaceuticals Inc.

• Ligand Pharmaceuticals Inc. Announces $353 Million Cash Dividend and Share Repurchase Authorization

  3/22/2007

• Ligand Pharmaceuticals Inc. Announces Fourth Quarter Results

  3/16/2007

• Ligand Pharmaceuticals Inc. to Hold 2006 Fourth Quarter Conference Call on March 15

  3/8/2007

• Ligand Pharmaceuticals Inc. Announces Changes and Additions to the Board of Directors

  3/2/2007

• Ligand Pharmaceuticals Inc. Completes Sale of AVINZA to King Pharmaceuticals®, Inc.

  2/27/2007

• Ligand Pharmaceuticals Inc. Announces Results Of Special Stockholder Meeting

  2/12/2007

• Ligand Pharmaceuticals Inc. Sets February 12, 2007 As Date For Special Meeting Of Stockholders

  1/25/2007

• Ligand Pharmaceuticals Inc. Appoints John L. Higgins Chief Executive Officer

  1/16/2007

• The Day In Review: Deals Dominate The News

  12/1/2006

• Ligand Pharmaceuticals Inc. Announces Initiation Of Clinical Trials For Thrombocytopenia Drug, LGD 4665

  11/30/2006

• Ligand Pharmaceuticals Inc. Announces Conversion Of All Outstanding 6% Convertible Subordinated Notes

  11/29/2006

• Ligand Pharmaceuticals Inc. Announces Financial Results For Third Quarter Of Fiscal 2006

  11/15/2006

• Ligand Pharmaceuticals Inc. Announces Conference Call On Third Quarter Financial Results

  11/14/2006

• Ligand Pharmaceuticals Inc. Files 12b-25 For Extension To File Third Quarter 10-Q

  11/10/2006

• Ligand Pharmaceuticals Inc. Announces Notice Of Redemption Of Convertible Subordinated Notes

  10/31/2006

• Eisai Company, Ltd. Announces Completion Of Acquisition of Four Oncology-Related Products From Ligand Pharmaceuticals Inc.

  10/26/2006

• Ligand Pharmaceuticals Inc. Renews Stockholder Rights Plan Trigger Set At 20%

  10/17/2006

• Jason M. Aryeh Elected To Ligand Pharmaceuticals Inc. Board Of Directors

  10/2/2006

• The Day In Review: Ligand Pharmaceuticals Inc. Sells Remaining Drugs

  9/8/2006

• Eisai Inc. Buys 4 Cancer Drugs From Ligand Pharmaceuticals Inc. For $205 Million

  9/8/2006